EUDA Health vs Charming Medical
EUDA and MCTA side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EUDA and MCTA compare
EUDA Health grew revenue faster over the last twelve months (70.0% versus −22.7% for Charming Medical).
Charming Medical keeps more of each dollar of sales as profit, with a net margin of −0.47% compared with −40.7% at EUDA Health.
EUDA Health scores higher on the StockData Score (5 against 3 for Charming Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EUDA | MCTA |
|---|---|---|
| Size and price | ||
| Share price | $15.80 | $29.35 |
| Change, 1 year | −74.8% | 33.3% |
| Beta (5Y) | 0.35 | 0.85 |
| Employees | 123 | 29 |
| StockData Score | ||
| Total score | 5 (better) | 3 |
| Valuation score | 0 | 0 |
| Growth score | 3 (better) | 0 |
| Performance score | 1 | 1 |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 70.0% (better) | −22.7% |
| Net income growth (TTM) | – | −102% |
| EPS growth (TTM) | – | −100% |
| Profitability | ||
| Gross margin | 43.9% | 99.3% (better) |
| Operating margin | −36.3% | −0.61% (better) |
| Net margin | −40.7% | −0.47% (better) |
| FCF margin | −36.7% | −32.4% (better) |
| Return on equity | −245% | −0.87% (better) |
| Return on invested capital | −227% | −13.7% (better) |
| Financial health | ||
| Debt / equity | – | 0.04 |
| Interest coverage | −10.8× | −1.9× (better) |
| Current ratio | 2.53 (better) | 1.89 |
| Piotroski F-score | 5 (better) | 2 |
| Ownership | ||
| Held by institutions | – | 0.24% |
| Held by insiders | 24.4% | 71.9% |
| Short interest, % of float | – | 11.5% |
Go deeper
- EUDA stock overview
- EUDA income statement
- EUDA valuation and score
- MCTA stock overview
- MCTA income statement
- MCTA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.